arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

download Export Data

Alpha Tau Medical Ltd.

DRTS

$13.15 ▲ +0.14 (+1.08%) at close

8 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Alpha Tau Medical Ltd. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.1B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -55.0% ↗

FCF / Share $-0.41 ↘

Trailing P/E —

Price / Book 15.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-42.63M

↓ -34.3% —

FCF / Share Free cash flow per share

$-0.41

↓ -29.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Financial Health

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
EPS Growth YoY (%)	-17.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-7.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	20.8% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	20.9% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-204.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	12.0% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-34.3% Weak ↓ Weak Declining Year-over-year change in net income	-8.9% Weak ↑ Weak Improving Year-over-year change in net income	13.6% Fair ↑ Fair Improving Year-over-year change in net income	-23.8% Weak ↑ Weak Improving Year-over-year change in net income	-207.0% Weak Weak Year-over-year change in net income	-6.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-29.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	10.3% Fair ↑ Fair Improving Year-over-year change in free cash flow	10.0% Fair ↑ Fair Improving Year-over-year change in free cash flow	-7.3% Weak ↑ Weak Improving Year-over-year change in free cash flow	-32.9% Weak Weak Year-over-year change in free cash flow	-12.8% Weak Weak Year-over-year change in free cash flow	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Effective Tax Rate (%) (%)	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	0.77x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.24x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Return on Invested Capital (%)	-55.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-111.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-4223.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-40.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	32.7% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	17.4% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-55.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-469%)	-50.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-438%)	-34.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-330%)	-32.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-313%)	78.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+423%)	105.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+602%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Debt to Equity (x)	—	—	0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	—	—	—	—	—
Interest Coverage (x)	-110.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-112.28x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-686.15x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-135.59x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	39.29x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	17.09x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	10.27x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-12.20M	$-13.72M	$-7.41M	$-5.84M	$-23.24M	$-15.60M	—	—
Debt / EBITDA (x)	—	—	-0.15x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Basic EPS, GAAP (USD)	$-0.53	$-0.45	$-0.42	$-0.53	$-0.67	$-0.22	$-0.25	—
Free Cash Flow per Share (USD)	$-0.41	$-0.31	$-0.35	$-0.39	$-0.36	$-0.27	$-0.24	—
Book Value per Share (USD)	$0.88	$0.89	$1.21	$1.53	$-0.86	$-0.21	$-0.01	—
Tangible Book Value per Share (USD)	$0.88	$0.89	$1.21	$1.53	$-0.86	$-0.21	$-0.01	—
Basic Weighted Avg Shares (shares)	80.58M	69.93M	69.38M	63.53M	40.53M	40.27M	33.82M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Working Capital (USD)	$67.79M	$55.55M	$78.65M	$102.14M	$28.24M	$45.37M	—	—
LT Debt (USD)	—	—	$5.25M	—	—	—	—	—
Total Equity (USD)	$77.10M	$62.67M	$84.47M	$105.66M	$-34.78M	$-8.43M	$-193.00K	$1.86M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 20-F ↗	FY 2024 Dec 31, 2024 20-F ↗	FY 2023 Dec 31, 2023 20-F ↗	FY 2022 Dec 31, 2022 20-F ↗	FY 2021 Dec 31, 2021 20-F ↗	FY 2020 Dec 31, 2020 20-F ↗	FY 2019 Dec 31, 2019 20-F ↗	FY 2018 Dec 31, 2018 20-F ↗
Depreciation Expense (USD)	$1.23M	$1.10M	$1.07M	$979.00K	$776.00K	$86.00K	$66.00K	—
Net Income, GAAP (USD)	$-42.63M	$-31.75M	$-29.16M	$-33.76M	$-27.27M	$-8.88M	$-8.37M	—
Operating Cash Flow (USD)	$-26.68M	$-19.78M	$-17.96M	$-23.88M	$-11.81M	$-7.25M	$-6.91M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 8 quarters

Alpha Tau Medical Ltd.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare DRTS with peers